Pregnancy and Neonatal Outcomes following Prenatal Exposure to Cabotegravir: Data from The Antiretroviral Pregnancy Registry (APR) (215325)

16/02/2022
10/11/2025
EU PAS number:
EUPAS45685
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

viiv-215325-protocol-orig-redact.pdf

English (1.02 MB - PDF) View document
Study results
Study report
Other information